Results

1–10 of 53 results for retinal vein occlusion

Aflibercept 8 mg in Treatment-Naive Macular Edema Secondary to Retinal Vein Occlusion: Primary Endpoint Results From the QUASAR Study
Seenu M. Hariprasad, MD
Annual Meeting Talks
2025
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on the Risk of Retinal Vein and Artery Occlusions
Aleksandra V. Rachitskaya, MD, FASRS
Annual Meeting Talks
2025
Retinal Vein Occlusion with Good Baseline Visual Acuity: Immediate Treatment vs. Initial Observation
Ajay E Kuriyan, MD, MS
Updates from the Field
2026
Central Retinal Vein Occlusion
Tamara Zompa, MD
Martin Charles, MD
Retina Image Bank: Images of the Week
2026
Branch Retinal Vein Occlusion with Retinal Neovascularization
Retina Image Bank: Images of the Week
2025
Retinal Arteriovenous Malformation
Korey Starkey
Retina Image Bank: Images of the Week
2025
Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Annual Meeting Talks
2024
Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion: 72-Week Results From the Phase 3 BALATON and COMINO Trials
Carl J Danzig, MD
Annual Meeting Talks
2024
Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion:72-Week Results From the Phase 3 BALATON and COMINO Trials
Carl J Danzig, MD
Updates from the Field
2024
Spatial Correlation Between Retinal Ischemia and Reactive Choroidal Changes in Retinal Vein Occlusion
Junyeop Lee, MD, PhD
Annual Meeting Talks
2022